2 Comments

Bayer Produces More Medical Things in the Future

Due to the combined effect of an aging population, lifestyle changes and other factors, chronic disease management needs of Chinese society continues to grow. National Health and Family Planning Commission issued “China National Nutrition and Chronic Disease Status Report (2015)” shows that Chinese citizens over the age of 18, and 25.2% had hypertension, 9.7% had diabetes, to cause enormous economic burden on society . The report also pointed out that China had 533 per 100,000 people die from chronic diseases, 86.6% of the total number of deaths.

Bayer has a strong product portfolio, including worship aspirin, Adalat and Glucobay products, including chronic disease, for the prevention and treatment of cardiovascular disease and diabetes and other major chronic disease played an important role, but also promoted the Bayer prescription drugs in China market outstanding performance.

Bayer’s new prescription drug products and indications are different therapeutic areas respectively occupied the leading position. By 2015, the novel oral anticoagulant Xarelto (rivaroxaban tablet) listed two new indications approved in China for the treatment of adults with deep vein thrombosis (DVT), reduced relapse after acute DVT DVT and pulmonary the risk of embolism (PE); and for having one or more risk factors for adult patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism. Xarelto break through the limitations of traditional anticoagulants, venous thrombosis in the two fields provides a convenient anticoagulation new choice worldwide have treated 15 million cases of patients. Currently, Xarelto ®? The Chinese market has become the leading new oral anticoagulants.

In the field of anti-cancer, Bayer will continue to the latest achievements in oncology research into leading drugs. Nexavar? Kidney cancer and liver cancer indications have been listed in China, one for the treatment of colorectal cancer tumors innovative drugs through the approval is expected in the near future. World Health Organization data show, colorectal cancer is the world’s most common cancer in China’s third largest incidence of malignant tumors. This innovative medicines will help more cancer patients to improve quality of life.

2 comments on “Bayer Produces More Medical Things in the Future

  1. Normally I don’t learn article on blogs, but I would like to say that this write-up very
    compelled me to try and do it! Your writing style has been amazed me.

    Thanks, very nice post.

  2. Fantastic goods from you, man. I’ve keep in mind
    your stuff prior to and you’re simply too magnificent. I really like what you’ve
    bought right here, certainly like what you are saying and the way during which you are
    saying it. You make it entertaining and you continue to care for to
    keep it smart. I cant wait to read much more from you.
    That is really a wonderful site.

Leave a Reply

Your email address will not be published. Required fields are marked *

Meizitang Soft Gel UK | Meizitang UK Suppliers | Meizitang Strong Version UK | Meizitang UK Reviews | Meizitang Botanical Slimming UK | Meizitang Botanical Slimming Capsules | Meizitang Capsules Side Effects | Meizitang UK Sale | Buy Meizitang UK | Meizitang Capsules UK | Cheap Viagra UK | Viagra UK Online | Buy Viagra UK